|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 47/26 | |||
| A61K 38/26 |
| (11) | Number of the document | 2175834 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08772467.0 |
| Date of filing the European patent application | 2008-07-09 | |
| (97) | Date of publication of the European application | 2010-04-21 |
| (45) | Date of publication and mention of the grant of the patent | 2011-02-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/069473 |
| Date | 2008-07-09 |
| (87) | Number | WO 2009/009562 |
| Date | 2009-01-15 |
| (30) | Number | Date | Country code |
| 948855 P | 2007-07-10 | US |
| (72) |
NG, Kingman, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | GLP-1-FC FUSION PROTEIN FORMULATION |
| GLP-1-FC FUSION PROTEIN FORMULATION |